A study published in September 2017, titled: ‘Quality of life after brachytherapy or bilateral nerve‐sparing robot‐assisted radical prostatectomy for prostate cancer: a prospective cohort’, compared patient quality of life after either brachytherapy or radical prostatectomy treatments.
Because prostate cancer and its treatment options involve the most intimate of male-related issues—erectile and urinary function—they generate a great deal of investigative scrutiny. From the physician's point of view, a prescribed treatment can be life changing, with both benefits and drawbacks for the male subject. More importantly, treatment can be lifesaving.
Prostate cancer is the most common form of cancer in men, and will directly or indirectly effect most of us in our lifetime. With new research showing that half of prostate cancer patients undergo treatment without knowing their treatment options, it is more important than ever to talk openly about this disease and the full range of choices available when deciding upon treatment.